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Abstract
Background: Lipid droplet (LD) formation and size regulation reflects both lipid influx and efflux, and is central in the 
regulation of adipocyte metabolism, including adipokine secretion. The length and degree of dietary fatty acid (FA) 
unsaturation is implicated in LD formation and regulation in adipocytes. The aims of this study were to establish the 
impact of eicosapentaenoic acid (EPA; C20:5n-3) in comparison to SFA (STA; stearic acid, C18:0) and MUFA (OLA; oleic 
acid, C18:1n-9) on 3T3-L1 adipocyte LD formation, regulation of genes central to LD function and adipokine 
responsiveness. Cells were supplemented with 100 μM FA during 7-day differentiation.
Results: EPA markedly reduced LD size and total lipid accumulation, suppressing PPARγ, Cidea and D9D/SCD1 genes, 
distinct from other treatments. These changes were independent of alterations of lipolytic genes, as both EPA and STA 
similarly elevated LPL and HSL gene expressions. In response to acute lipopolysaccharide exposure, EPA-differentiated 
adipocytes had distinct improvement in inflammatory response shown by reduction in monocyte chemoattractant 
protein-1 and interleukin-6 and elevation in adiponectin and leptin gene expressions.
Conclusions: This study demonstrates that EPA differentially modulates adipogenesis and lipid accumulation to 
suppress LD formation and size. This may be due to suppressed gene expression of key proteins closely associated with 
LD function. Further analysis is required to determine if EPA exerts a similar influence on LD formation and regulation 
in-vivo.
Background
Adipose tissue is a complex dynamic tissue facilitating
energy storage, which also exerts considerable influence
on whole body metabolic function through secreted hor-
mones and adipokines [1]. Importantly, the size of adipo-
cytes is an important determinant of the profile of the
adipokines secreted, with large adipocytes predominately
releasing pro-inflammatory factors such as monocyte
chemoattractant protein-1 (MCP-1) and interleukin-6
(IL-6), and reduced anti-inflammatory adipokines includ-
ing leptin and adiponectin [2-4]. In adipocytes, triacylg-
lycerols (TAG) are sequestered within lipid droplets
(LDs), with over 95% of each mature adipocyte is com-
posed of TAG. LD formation is the major pathway regu-
lating adipocyte size [5].
LDs are far from inert vesicles, and are composed of a
central core of neutral lipids surrounded by a phospho-
lipid monolayer that occurs in close association with a
complex array of proteins [6]. Crucial in the genesis of
LDs in adipocyte differentiation from precursor fibro-
blasts is the developmental program initiated and regu-
lated by key adipogenic transcription factors such as
peroxisome proliferator-activated receptor γ (PPARγ) [7].
The maintenance of LDs in mature adipocytes is regu-
lated in part both by the TAG influx dictated by enzymes
including lipoprotein lipase (LPL), and the predominant
enzymes regulating TAG efflux, including adipose trig-
lyceride lipase (ATGL, also known as desnutrin and
Pnpla2) and hormone sensitive lipase (HSL, also known
as  Lipe) [8-10]. The activity of these efflux lipolytic
enzymes is orchestrated by protein-protein interactions
with Perilipin A, a lipid droplet scaffold protein [11].
Alterations in HSL expression has limited impact on LD
size, however, alterations in ATGL activity profoundly
influence LD size, independent from Perilipin A activity
[12]. However, Perilipin A null mice have impaired LD
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formation, demonstrating that Perilipin A also uniquely
influences LD function [13]. Whilst the abundance of
ATGL and Perilipin A demonstrate the importance of
lipolytic control in regulating LD size, RNAi screening
unexpectedly highlighted a close association and impor-
tance of the cell death-inducing DFF45-like effector
(CIDE) domain containing protein (Cidea) with LD size
[14]. The mice Cidea (homologous to humans CIDEA),
previously described as a mitochondria-associating pro-
tein, associates with LDs and negatively regulates lipoly-
sis, promoting increased LD size. Both Perilipin A and
Cidea are transcriptionally regulated by PPARγ, demon-
strating the importance of this pathway in the regulation
of LD formation and size [15,16].
Depending on the length and degree of unsaturation,
FAs have been predicted to influence PPARγ-regulated
gene expression and subsequent LD formation during
adipocyte differentiation [17,18]. Recently, adipocyte size
has been noted to be influenced by the FA composition in
the LDs that is regulated by delta-9 desaturase/stearoyl
Co-A desaturase 1 (D9D/SCD1) gene [19] that is PPARγ-
dependent [20]. Potent in the regulation of PPARγ is the
long chain n-3 PUFA, eicosapentaeneoic acid (EPA).
Diets enriched in EPA lower adipose tissue mass and sup-
press obesity development in rats [21]. Within adipocytes
EPA is known to induce expression of genes for mito-
chondrial biogenesis and oxidative metabolism, increas-
ing the catabolism of lipids [22,23]. Furthermore, EPA has
been previously reported to attenuate pro-inflammation
in favour of anti-inflammatory adipokines [23]. Yet in
spite of this, the impact of EPA on the molecular mecha-
nisms governing the key pathways dictating adipocyte
size and the biogenesis of intracellular LDs has yet to be
analysed.
In this study, the differential effects of 7-day period of
EPA (C20:5n-3) compared with stearic (STA, C18:0) and
oleic acids (OLA, C18:1n-9) in differentiating 3T3-L1
adipocytes was assessed on the basis of the molecular fac-
tors critical in governing LD biogenesis. The ability of the
resultant adipocytes to modulate the expression of pro-
inflammatory, compared to anti-inflammatory adipok-
ines upon bacterial endotoxin lipopolysaccharide (LPS)
challenge were also evaluated. It was hypothesised that
EPA would suppress LD formation and enhance the anti-
inflammatory adipokines in response to LPS challenge.
Results
The effect of FA on LD formation in 3T3-L1 adipocytes
A representative image of LD size and number of 3T3-L1
adipocytes which underwent differentiation in the pres-
ence of differing FA is shown in Figure 1A. Adipocytes
differentiated in the absence of added FA (CTRL), or with
STA and OLA after 7 days resulted in larger LDs than
that observed with EPA treatment. The smaller LD
observed with EPA treatment reduced total lipid accumu-
lation by 20% (P < 0.05), as measured using Oil Red O
staining, but no difference was observed in other groups
compared with CTRL (Figure 1B).
Gene expression of adipogenic and LD factors
The impact of EPA, in comparison to STA and OLA, on
PPARγ and GLUT4, is shown in Figure 2A. EPA treat-
ment during adipocyte differentiation decreased PPARγ
by nearly 50% compared with STA or OLA. GLUT4 gene
expression was unaltered by all treatments. Furthermore,
genes central to LD formation (Cidea and Perilipin A)
were also measured (Figure 2B). EPA significantly
decreased Cidea gene expression by 50% (P < 0.05) com-
pared with CTRL or STA. Comparatively, OLA increased
Cidea gene expression. Perilipin A gene expression was
unaltered from CTRL in all groups.
Figure 1 Effects of FAs on adipocyte morphology and lipid accu-
mulation. The 3T3-L1 pre-adipocytes were incubated in growth medi-
um supplemented with adipogenic factors (520 μM IBMX, 200 nM Dex 
and 2 μg/mL insulin). FAs (100 μM) of EPA, STA or OLA were included 
throughout 7 days of adipocyte differentiation. A) Cell morphology of 
differentiated adipocytes analysed with phase contrast microscopy 
before (a - d) and after (e - h) Oil Red O stain. B) Stained lipid fraction 
was measured spectrophotometrically on Day 8 at A520 nm. Values were 
calculated as percent lipid content versus vehicle control cells treated 
with 2% BSA + 100% ethanol alone (CTRL) and are expressed as means 
± SEM (n = 6). Values with different superscript letters are significantly 
different at P < 0.05 by Tukey's post hoc test.
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Gene expression of lipolytic enzymes
As shown in Figure 3, there was a significant increased
expression of LPL and HSL genes in adipocytes differen-
tiated with all types of FAs relative to CTRL (P < 0.05).
More than 2-fold increase in LPL gene expression was
noted in adipocytes differentiated in the presence of EPA
and STA, compared with CTRL. The expression of HSL
gene was also significantly elevated by both EPA and
STA, compared with CTRL (P < 0.05).
Gene expression of D9D/SCD1
A significant elevation of D9D/SCD1 gene expression
was evident in adipocyte differentiated with STA (131%)
relative to CTRL (P < 0.05) (Figure 4). When EPA was
introduced, the adipocytes expressed 62% less D9D/
SCD1 gene expression compared with CTRL (P < 0.05).
Gene expression of inflammatory adipokines upon LPS 
challenge
The changes in the inflammatory adipokines upon LPS
challenge in differentiated-adipocytes are shown in Table
1. The elevation of MCP-1 gene expression after LPS
treatment was significantly lower in EPA-differentiated
adipocytes, compared with CTRL or STA (5.6-fold vs >
13-fold) (P < 0.05). Similarly, the expression of IL-6 gene
was 4.1-fold less after EPA treatment compared with
STA. Alternatively, the gene expressions of adiponectin
(2.2-fold vs 1.1-fold) and leptin (2.8-fold vs 1.2-fold) were
significantly elevated upon LPS challenge in EPA com-
pared with STA treatment.
Figure 3 Effects of FAs on mRNA expression of lipolytic enzymes, 
LPL and HSL. Adipocytes were differentiated in the presence of 100 
μM FA or vehicle control. All FA treatments, EPA, STA and OLA, in-
creased gene expression of LPL and HSL, compared with vehicle con-
trol (CTRL). All values are means ± SEM of percent gene expression 
relative to CTRL, where cDNA levels were normalised by cyclophilin 
levels (n = 4). Values with different superscript letters are significantly 
different at P < 0.05 by Tukey's post hoc test.
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Figure 4 Effects of FAs on mRNA expression of D9D/SCD1. Cells 
were differentiated in the presence of 100 μM FA or vehicle control. 
EPA, in contrast to STA and OLA, resulted in a significant inhibition of 
D9D/SCD1 gene expression. All values are means ± SEM of percent 
gene expression relative to CTRL, where cDNA levels were normalised 
by cyclophilin levels (n = 4). Values with different superscript letters are 
significantly different at P < 0.05 by Tukey's post hoc test.
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Figure 2 Effects of FAs on mRNA expression of (A) adipogenesis; 
PPARγ and GLUT4, and (B) LD size; Cidea and Perilipin A. Cells were 
differentiated in the presence of 100 μM FA or vehicle control. EPA, in 
contrast to STA and OLA, resulted in a significant inhibition of Cidea 
and PPARγ gene expressions but not Perilipin A or GLUT4. All values are 
means ± SEM of percent gene expression relative to CTRL, where cDNA 
levels were normalised by cyclophilin levels (n = 4). Values with differ-
ent superscript letters are significantly different at P < 0.05 by Tukey's 
post hoc test.
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Discussion
LDs are important organelles, not only for cellular energy
storage, but emerging research demonstrates a central
role in intracellular signalling and adipokine regulation.
Thus, the formation and regulation of LDs may contrib-
ute to the metabolic disease progression towards type 2
diabetes and cardiovascular disease evident in obesity.
FAs are important in both providing the substrate for LD
formation, and may also be central in regulating LD for-
mation and size. Previously, long chain n-3 PUFA have
been reported to suppress LD formation [24,25],
although comparison to other FA and putative mecha-
nisms is lacking. The present study demonstrated a
marked suppression of LD formation in 3T3-L1 adipo-
cytes maintained in the presence of EPA, when compared
to either a SFA or MUFA. Of the mechanisms governing
LD formation and regulation, EPA suppressed PPARγ,
Cidea and D9D/SCD1 gene expressions, while maintain-
ing the expression of lipolytic genes, including LPL and
HSL. A key regulator of adipogenesis is PPARγ, and FA
sensitive transcriptional regulator of many thousands of
adipocyte-specific genes [7].
Specifically, both n-6 and n-3 PUFA species directly
influence PPAR activity [23]. Although known as an acute
agonist and regulator of the PPARγ gene [26], chronic
EPA exposure was shown to suppress this gene expres-
sion. Many of the subsequent genes analysed in the pres-
ent study are PPAR-dependent, yet the responsiveness
was varied, suggesting alteration of PPAR activity was not
the sole regulating factor suppressing LD formation in
the presence of EPA.
Cidea and Perilipin A are proteins highly localised to
LDs of adipose tissue that are important for FA esterifica-
tion to TAG and lipid mobilisation [14,27]. Cidea and
Perilipin A are known to be closely regulated by PPARγ
[16]. Cidea acts as a shield for fat storage that drives lipid
accumulation even in cells that rarely store fat [28]. Simi-
larly, Cidea expression is abundantly upregulated with
high SFA feeding [14]. Conversely, animals or humans
with Cidea deficiency display lean phenotypes with resis-
tance to diet-induced obesity [29]. In this study, Cidea
gene expression was downregulated in adipocytes treated
with EPA but not after STA or OLA treatments.
Perilipins are a class of proteins closely associated with
LD formation in adipocytes [30], yet the critical relevance
of this gene in the regulation of lipid mobilisation upon
nutritional challenges in adipocytes is uncertain. An ele-
vated Perilipin A level in obese humans [31] is inconsis-
tent with decreased diet-induced obesity in Perilipin A-
overexpressed mice [32]. In this study, we found that EPA
significantly affected Cidea but not Perilipin A. The sub-
stantial reduction in Cidea gene expression by EPA, but
not by STA or OLA, is consistent with the decreased LD
size and PPARγ, suggesting that Cidea (along with
PPARγ) is the prime target for EPA in adipocytes, not
Perilipin A.
Another possible mechanism governing LD formation
is linked to D9D/SCD1. Desaturases are other enzymes
that are greatly affected by the degree of unsaturation of
FAs. D9D/SCD1 is one particular desaturase that has
been highly discussed in terms of SFA-rich diet-induced
obesity. D9D/SCD1 is a key regulatory enzyme required
to convert SFA to MUFA that participate in lipid metabo-
lism in adipocytes [33,34]. The importance of D9D/SCD1
expression in the formation of larger adipocytes has also
been recently noted [19]. Contrary to the upregulation
shown by SFA and MUFA, dietary PUFA (arachidonic
and α-linolenic acids) consistently decreased the expres-
sion of D9D/SCD1 in liver and adipose tissue of obese
models [35,36]. Similar to the shorter chain n-3 PUFA α-
linolenic acids, our study is the first to confirm a distinct
downregulation of D9D/SCD1 in adipocytes after longer
chain n-3 PUFA EPA treatment, in contrast to the upreg-
ulation shown by STA and OLA.
Like many other adipocyte-specific genes, D9D/SCD1
is also upregulated by PPARγ during adipogenesis, while
PPARγ expression is not controlled by D9D/SCD1 [37].
Whilst D9D/SCD1 is positively correlated with PPARγ to
Table 1: Gene expression of inflammatory adipokines upon LPS challenge in adipocytes after differentiation with EPA, STA, OLA or 
vehicle control
Gene expression of 
adipokines (fold change/
FA treatment (100 μM)
CTRL EPA STA OLA
MCP-1 13.9 ± 3.1a 5.6 ± 0.8b 13.4 ± 3.3a 6.6 ± 1.8ab
IL-6 7.2 ± 0.8ab 5.5 ± 0.8b 9.6 ± 0.9a 5.2 ± 0.8b
Adiponectin 1.4 ± 0.1ab 2.0 ± 0.4b 1.1 ± 0.2a 1.3 ± 0.2ab
Leptin 0.9 ± 0.2a 2.8 ± 1.0b 1.2 ± 0.2a 1.0 ± 0.3a
Values are means ± SEM of n = 4, with different superscript letters are significantly different at P < 0.05 by Tukey's post hoc test.Manickam et al. Lipids in Health and Disease 2010, 9:57
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increase lipogenesis in adipocytes [20,37], the signifi-
cance of reducing the D9D/SCD1 expression to reverse
obesity has been constantly discussed [38,39]. Many anti-
obesity compounds are designed with the aim of reducing
the level of D9D/SCD1 [40,41], similar to the effect
shown here by EPA. Bigger LDs has been shown to
strongly correlate with the upregulation of PPARγ, D9D/
SCD1 and Cidea in adipocytes supplemented with STA
and OLA. As illustrated in Figure 5, it is clear that the
anti-adipogenic effect of EPA is regulated by the reduc-
tion in PPARγ level, which decreased D9D/SCD1 and
Cidea gene expressions, followed by a decline in lipid
accumulation to induce smaller LDs. However, it is not
known whether D9D/SCD1 and Cidea are independent
of each other.
I t is plausible that modifications in lipolyic pathways
influence LD formation and size regulation. LPL and HSL
are the major rate-limiting lipases for a balanced lipolysis
and lipogenesis in adipocytes. In this study the degree of
unsaturation of FAs did not alter the mRNA levels of LPL
and HSL in adipocytes. Both EPA and STA (and OLA to
some extent) affect the expressions of these lipases at the
same magnitude in adipocytes. This results support pre-
vious studies on the influence of FAs on lipolytic enzymes
gene expressions. Dietary fish oil supplementation
increased LPL gene expression in adipose tissue of
humans and rats [42,43]. In comparison to other FAs, n-3
PUFA-rich perilla oil did not change LPL expression in
rat adipose tissue although a reduced adipogenesis was
observed [44]. Similarly, HSL level is only slightly affected
by the degree of FA unsaturation, confirming a previous
notion [45]. It is speculated that like other FAs, EPA may
play a role in lipolytic regulation, however this does not
influence the biogenesis of LDs in adipocytes.
Adipocytes produce numerous amounts of inflamma-
tory adipokines upon stimulation. Hypertrophied adipo-
cytes are insulin resistant, and demonstrate greater
secretion of low grade inflammatory cytokines, chemok-
ines and vascular proteins [46]. Our study demonstrated
that adipocytes differentiated with EPA suppressed gene
expressions of LPS-induced pro-inflammatory adipok-
ines, MCP-1 and IL-6. Alternatively, similar treatment
resulted in elevated adiponectin and leptin gene expres-
sions compared with SFA, complementing data described
elsewhere [47,48]. Thus, EPA-treated adipocytes, with
smaller LDs, have improved inflammatory response.
Conclusion
EPA, being the predominant long chain n-3 PUFA found
in marine oils, suppresses LD formation and size in 3T3-
L1 adipocytes, in comparison to other FAs. Several lines
of evidence suggest a beneficial impact of EPA on lipid
accumulation and body weight regulation [21,23,49].
Suppression of LD formation and size may be one novel
contributing factor. In addition to examining LD size, we
explored the gene analysis of known regulators of LD
function. Interestingly, addition of EPA during adipocyte
differentiation decreased PPARγ, Cidea and D9D/SCD1
without affecting GLUT4 and Perilipin A expressions, as
compared with SFA. Such effects concomitantly sup-
pressed the total lipid accumulation and biogenesis of
LDs.  C om pl e me n t ing  t his  da ta  is  a lt e r ed e x p r ess io n of
adipokines following acute LPS exposure, with EPA-
treated adipocytes expressing improved inflammatory
response. Thus, EPA is a novel regulator of LD formation,
a key intracellular organelle central to the function and
regulation of adipocyte metabolism.
Methods
Reagents
Dexamethasone (Dex; D4902), isobutylmethylxanthine
(IBMX; I5879), insulin (I5500), low-endotoxin FA-free
BSA (A8806), LPS (L6529), EPA (44864), STA (85679)
and OLA (O1383) (all FAs were with purity > 99%) were
obtained from Sigma (St. Louis, MO). Fetal bovine serum
(FBS) and DMEM were purchased from Invitrogen
(Carlsbad, CA). FAs were dissolved in 100% ethanol as
stock solutions of 100 mM while LPS was dissolved in
dH2O at 1 mg/mL stock. All stock solutions were stored
in the dark at -20°C before use. All other reagents were of
analytical grade.
Cell culture
The 3T3-L1 mouse embryo fibroblasts were obtained
from the American Type Culture Collection (Rockville,
MD). The adipocyte cell culture and their differentiation
Figure 5 Possible mechanism involved in FA-regulated LD forma-
tion in adipocytes. Both SFA (stearic acid) and n-3 PUFA (eicosapen-
taenoic acid) have similar magnitude of effects towards lipolysis 
controlled by LPL and HSL. In contrast to upregulation shown by SFA, 
n-3 PUFA decreased PPARγ level, which may be responsible for the re-
duction of D9D/SCD1 and Cidea expressions, leading to smaller LDs. 
The levels of GLUT4 and Perilipin A remain unchanged upon FA treat-
ment.
Glycerol
LD
Glycerol
LD
SFA
(Stearic acid)
n-3 PUFA
(Eicosapentaenoic acid)
FA uptake
FA uptake
LD
LD
LPL
HSL
LPL
HSL Lipolysis
SCD1
SCD1
Cidea
Cidea
Lipolysis
PPAR PPAR
Perilipin A
Perilipin A
GLUT4 GLUT4Manickam et al. Lipids in Health and Disease 2010, 9:57
http://www.lipidworld.com/content/9/1/57
Page 6 of 8
from 3T3-L1 pre-adipocytes were carried out as
described previously [50]. Briefly, cells were seeded in 6-,
12- and 24-well tissue culture plates and maintained in
growth medium containing DMEM supplemented with
10% FBS, 2 mM/L glutamine, 100 U/L penicillin and 100
μg/mL streptomycin in a humidified atmosphere of 95%
air/5% CO2 at 37°C. At post-confluent, adipogenesis of
3T3-L1 was induced with growth media containing 520
μM IBMX, 200 nM Dex and 2 μg/mL insulin. After 3 days
of exposure to the differentiation medium, cells were
maintained in growth medium containing insulin alone.
FA treatment was introduced throughout all 7 days of cell
differentiation at physiological concentration of 100 μM.
STA was diluted in warm growth medium containing 2%
BSA and incubated for 4 hours at 37°C until dissolved. All
other FAs were freshly prepared from the stock solution
and diluted with growth medium containing 2% BSA. A
corresponding amount of 2% BSA + 100% ethanol was
used as the vehicle control (CTRL). For LPS stimulation,
mature adipocytes were serum starved for 2 h prior to
treatment with 1 μg/mL of LPS for 60 min at 37°C to
induce inflammation.
Oil Red O staining
After appropriate treatment, adipocytes were washed
with cold phosphate-buffered saline (PBS; pH 7.4) and
fixed with 4% paraformaldehyde solution in PBS. Cells
were stained with freshly prepared Oil Red O dye (0.5%
(w/v) dissolved in isopropanol and diluted at 3:2 ratio of
dye:water). Cells were washed thoroughly with distilled
water prior to quantification. Spectrophotometric analy-
sis of the stain was performed by dissolving the stained
LDs with isopropanol and measuring at A520 nm [51]. The
values were calculated as percentage of the vehicle con-
trol and expressed as means ± SEM (n = 6).
RNA isolation and gene expression quantification
Total RNA was extracted from 3T3-L1 adipocytes using
Tri-reagent (PE Applied Biosystems, Foster City, CA).
The purity of the RNA was measured at A260 nm/A280 nm
using Nanodrop 1000 (Thermo Fisher Scientific Inc, MA,
USA) with ratio values of ~2.0. The cDNAs was synthe-
s i s e d  f r o m  2  μ g  o f  R N A  u s i n g  h i g h  c a p a c i t y  R N A -t o -
cDNA reverse transcriptase kit in a total of 20 μL of reac-
tion volume (PE Applied Biosystems). Reverse transcrip-
tion was performed with sample incubation at 42°C for 1
h, followed by 99°C for 5 min and 4°C for another 5 min.
RT-PCR amplifications were performed from 1 μL cDNA
diluted at 1:20 using each of the gene-specific primer sets
(GeneWorks Pty Ltd, SA, Australia). The oligonucleotide
sequence of the forward (sense) and reverse (antisense)
primers used for amplification were as in Table 2. Each
primer set was used at a concentration of 200 μM in a
final volume of 14 μL using Power SYBR® Green PCR
Master Mix (PE Applied Biosystems). All PCR reactions
were performed using a fluorometric thermal cycler
(7500 Fast Real-Time PCR System, PE Applied Biosys-
tems). The ΔΔCT method was used to measure relative
quantification, where values were normalised to the ref-
erence gene (cyclophilin). Individual CT values are means
of triplicate measurements, with repeatability measure-
ment of < 0.5. Separate control experiments were used to
demonstrate that the efficiency of target and reference
amplifications were equal.
Statistical analysis
All results are expressed as means ± SEM. The statistical
significance of differences among groups was determined
by one-way analysis of variance (ANOVA) using the SPSS
package program version 17.0 (SPSS, Chicago, IL). The
Table 2: Gene specific forward and reverse primer sequences used for RT-PCR
Gene Forward primer (5' - 3') Reverse primer (5' - 3') NCBI accession number
Adiponectin AAGGACAAGGCCGTTCTCT TATGGGTAGTTGCAGTCAGTTGG NM_009605
Cidea TGCTCTTCTGTATCGCCCAGT GCCGTGTTAAGGAATCTGCTG NM_007702
Cyclophilin TCTGCTGTCTTTGGAACTTTGTC CTGATGGCGAGCCCTTG NM_008907
D9D/SCD1 ATGCCGGCCCACATGCTCCAA TCAGCTACTCTTGTGACTCCC NM_009127
GLUT4 TGTGGCCTTCTTTGAGATTGG CTGAAGAGCTCGGCCCACAA NM_009204
HSL CCTACTGCTGGGCTGTCAA CCATCTCGCACCCTCACT NM_010719
IL-6 ACAAGTCGGAGGCTTAATTAGACAT TTGCCATTGCACAACTCTATTC NM_031168
Leptin TCCAGAAAGTCCAGGATGACAC CACATTTTGGGAAGGCAGG NM_008493
LPL AGTAGACTGGTTGTATCGGG AGCGTCATCAGGAGAAAGG NM_008509
MCP-1 CTTCCTCCACCACCATGCA CCAGCCGGCAACTGTGA NM_011333
Perilipin A TGCTGGATGGAGACCTC ACCGGCTCCATGCTCCA NM_001113471
PPARγ GGAATGGGAGTGGTCATCCA CCCACCAACTTCGGAATC NM_001127330Manickam et al. Lipids in Health and Disease 2010, 9:57
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results were considered to be significant if the value of P
was < 0.05 using Tukey's post hoc test.
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